Clincosm LogoSign in Get a demo

Lymphoma, Mantle-Cell

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Lymphoma, Mantle-Cell Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

Recruiting
  • Lymphoma, Mantle-Cell
  • Barretos, Brazil
  • +150 more
Jan 27, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Lymphoma, Mantle-Cell
  • (no location specified)
Dec 22, 2022

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Wuhu, Anhui, China
  • +22 more
Dec 8, 2022

Lenalidomide With Tumor Flare Reaction and High Tumor Burden in

Recruiting
  • Lymphoma, Mantle-Cell
  • Graz, Austria
  • +86 more
Oct 19, 2022

Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

Recruiting
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • +2 more
  • Stanford, California
  • +6 more
Oct 19, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Stanford, California
  • +61 more
Aug 17, 2022

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Lymphoma, Mantle-Cell Trial in Italy (Venetoclax)

Active, not recruiting
  • Lymphoma, Mantle-Cell
  • Alessandria, Italy
  • +34 more
Aug 1, 2022

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Allogeneic Gamma Delta (?d) CAR T Cells

Enrolling by invitation
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • Stanford, California
  • +4 more
Jun 7, 2022

Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)

Completed
  • Lymphoma, Mantle-Cell
  • Recurrent Lymphoma, Mantle-Cell
  • ABT-199 and Ibrutinib Combination
  • Duarte, California
  • +3 more
May 22, 2022

Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Lymphoma
  • +4 more
  • IM19 CAR-T cells
  • +2 more
  • (no location specified)
Nov 30, 2021

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Austria, Switzerland (BeEAM, BEAM)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • +2 more
  • Linz, Austria
  • +3 more
Jul 29, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

Lymphoma, Mantle-Cell Trial in Czechia (Polatuzumab vedotin, Bendamustine Hydrochloride, Rituximab)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Polatuzumab vedotin
  • +2 more
  • Brno, Czechia
  • +6 more
May 28, 2021

Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)

Completed
Has Results
  • Non-Hodgkin Lymphoma
  • +8 more
  • La Jolla, California
  • +10 more
Apr 27, 2021

REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Anyang, Korea, Republic of
  • +12 more
Apr 6, 2021

Bortezomib Treatment on Mantle Cell Lymphoma in Chinese

Completed
  • Lymphoma, Mantle-Cell
    • Beijing, China
    • +8 more
    Nov 5, 2020

    Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Mantle-Cell
    • Ahmedabad, India
    • +7 more
    Aug 5, 2020

    Kinetics of Lymphoid Cells in Monoclonal B-cell Lymphocytosis,

    Completed
    • Lymphoma, Mantle-cell
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 13, 2020

      Lymphoma, Mantle-Cell Trial in Stanford (biological, procedure, drug)

      Completed
      Has Results
      • Lymphoma, Mantle-Cell
      • CpG-MCL vaccine
      • +7 more
      • Stanford, California
        Stanford University Medical Center
      Jan 8, 2020

      Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)

      Completed
      Has Results
      • Lymphoma, Mantle-Cell
      • Tositumomab and Iodine I 131 Tositumomab followed by CHOP
      • (no location specified)
      Nov 19, 2019